 |
HIV Treatment Naive Studies
There are now several HIV treatment options for people with HIV infection who have not yet been treated. Most people who receive treatment and take their medications as directed have a good result. This is usually determined by measuring the amount of HIV in the blood (viral load). The best response is when HIV cannot be found (less than 50 copies/mL) in the blood. This is also called undetectable. However, it has recently become clear that some people with HIV who are receiving effective HIV drugs continue to have more health problems than people without HIV infection. Sometimes there is damage to organs in the body, including bones, kidneys and the brain.
If you have never taken medications to treat your HIV, or you have only taken HIV medications for a short period of time, the UCLA CARE Center has studies that may be of interest to you:
HIV and Kidney Disease (ACTG 5296)
This study will examine if a medication for kidney disease (sevelamer carbonate) may reduce bacteria levels and damage to the immune system caused by HIV.
HIV and Starting Treatment (ACTG 5303)
This study is for HIV+ men and women who have NEVER taken HIV medications and examines the effects of two combination HIV medication regimens on HIV viral load, the bones, the kidneys and the brain.
For more information about the UCLA CARE Center's clinical trials and research studies, please contact:
Phone: (310) 557-9062
Email: CAREOutreach@mednet.ucla.edu
